Table 3.
Estimation of overdiagnosis in women aged 50-74 years in the Netherlands, 2009-11
| Parameters | Estimate | Row | Comments |
|---|---|---|---|
| No of breast cancers diagnosed in women aged 50-74 in 2009-11*: | |||
| In situ | 4422 | (1) | |
| Stage 1 | 12 804 | (2) | |
| Stage 2+ | 10 270 | (3) | |
| Not staged | 186 | (4) | |
| Total | 27 682 | (5) | |
| No of screen detected breast cancers† | 16 965 | (6) | |
| % of screen detected breast cancers | 61 | (7) | (6)/(5) |
| Estimation of overdiagnosed in situ and stage 1 breast cancers: | |||
| No of extra cancers, considering 57% extra cancers | 9819 | (8) | ((1)+(2))×0.57 (extra cancer proportion of 57% from supplementary table S2) |
| No of screen detected breast cancers representing clinical lead time | 960 | (9) | 612 breast cancer deaths avoided because of screening (from row 10 of table 2 multiplied by 3/2) |
| No of overdiagnosed breast cancers | 8859 | (10) | (8)−(9) |
| Breast cancers overdiagnosed among women invited to screening (%) | 32 | (11) | (10)/(5) |
| Breast cancers overdiagnosed among women with screen detected breast cancer (%) | 52 | (12) | (10)/(6) |
| Overdiagnosed in situ and stage 1 cancer among women invited to screening (%) | 51 | (13) | (10)/((1)+(2)) |
Source: Integraal Kankercentrum Nederland.
Source: Dutch National Evaluation Team, 2014.